Jaffetilchin Investment Partners LLC Takes $368,000 Position in Walgreens Boots Alliance Inc (WBA)

Jaffetilchin Investment Partners LLC purchased a new stake in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 4,761 shares of the pharmacy operator’s stock, valued at approximately $368,000. Jaffetilchin Investment Partners LLC owned about 471.60% of Walgreens Boots Alliance as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors also recently modified their holdings of WBA. Schaller Investment Group Inc. acquired a new stake in shares of Walgreens Boots Alliance in the first quarter valued at approximately $208,000. Oarsman Capital Inc. lifted its position in shares of Walgreens Boots Alliance by 23.0% in the first quarter. Oarsman Capital Inc. now owns 39,429 shares of the pharmacy operator’s stock valued at $3,275,000 after buying an additional 7,383 shares during the last quarter. Hyman Charles D lifted its position in shares of Walgreens Boots Alliance by 0.3% in the first quarter. Hyman Charles D now owns 110,158 shares of the pharmacy operator’s stock valued at $9,149,000 after buying an additional 277 shares during the last quarter. Boston Private Wealth LLC lifted its position in shares of Walgreens Boots Alliance by 3.3% in the first quarter. Boston Private Wealth LLC now owns 173,152 shares of the pharmacy operator’s stock valued at $14,380,000 after buying an additional 5,550 shares during the last quarter. Finally, BB&T Securities LLC lifted its position in shares of Walgreens Boots Alliance by 24.3% in the first quarter. BB&T Securities LLC now owns 73,390 shares of the pharmacy operator’s stock valued at $6,095,000 after buying an additional 14,324 shares during the last quarter. 61.18% of the stock is owned by hedge funds and other institutional investors.

In other Walgreens Boots Alliance news, Director William C. Foote sold 2,736 shares of the firm’s stock in a transaction on Thursday, November 2nd. The stock was sold at an average price of $67.37, for a total transaction of $184,324.32. Following the transaction, the director now owns 16,415 shares in the company, valued at approximately $1,105,878.55. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director John Anthony Lederer acquired 20,000 shares of the stock in a transaction on Thursday, October 26th. The shares were bought at an average price of $67.00 per share, for a total transaction of $1,340,000.00. Following the purchase, the director now owns 50,000 shares in the company, valued at $3,350,000. The disclosure for this purchase can be found here. 14.80% of the stock is owned by company insiders.

Walgreens Boots Alliance Inc (WBA) opened at $73.25 on Friday. The firm has a market capitalization of $71,493.78, a P/E ratio of 14.15, a PEG ratio of 1.29 and a beta of 1.22. The company has a debt-to-equity ratio of 0.45, a quick ratio of 0.59 and a current ratio of 1.07. Walgreens Boots Alliance Inc has a 52 week low of $63.82 and a 52 week high of $88.00.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its earnings results on Wednesday, October 25th. The pharmacy operator reported $1.31 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.21 by $0.10. The company had revenue of $30.15 billion for the quarter, compared to analyst estimates of $29.93 billion. Walgreens Boots Alliance had a return on equity of 18.36% and a net margin of 3.45%. The firm’s quarterly revenue was up 5.3% compared to the same quarter last year. During the same quarter last year, the company earned $1.07 earnings per share. research analysts expect that Walgreens Boots Alliance Inc will post 5.54 EPS for the current year.

Walgreens Boots Alliance declared that its board has approved a share buyback program on Wednesday, October 25th that authorizes the company to buyback $1.00 billion in outstanding shares. This buyback authorization authorizes the pharmacy operator to reacquire shares of its stock through open market purchases. Stock buyback programs are often an indication that the company’s board of directors believes its shares are undervalued.

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, December 12th. Shareholders of record on Monday, November 13th were paid a dividend of $0.40 per share. The ex-dividend date was Friday, November 10th. This represents a $1.60 dividend on an annualized basis and a yield of 2.18%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is presently 42.33%.

A number of analysts have recently issued reports on the company. Royal Bank of Canada assumed coverage on Walgreens Boots Alliance in a research report on Tuesday, September 19th. They issued an “outperform” rating and a $96.00 price objective for the company. Needham & Company LLC reaffirmed a “buy” rating and issued a $94.00 price objective on shares of Walgreens Boots Alliance in a research report on Saturday, September 16th. BidaskClub cut Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a research report on Tuesday, September 12th. Jefferies Group reaffirmed a “buy” rating and issued a $95.00 price objective on shares of Walgreens Boots Alliance in a research report on Thursday, September 7th. Finally, Loop Capital assumed coverage on Walgreens Boots Alliance in a research report on Thursday, August 24th. They issued a “buy” rating and a $95.00 price objective for the company. One analyst has rated the stock with a sell rating, nine have given a hold rating, thirteen have given a buy rating and one has given a strong buy rating to the stock. The stock has an average rating of “Buy” and a consensus price target of $86.47.

TRADEMARK VIOLATION NOTICE: “Jaffetilchin Investment Partners LLC Takes $368,000 Position in Walgreens Boots Alliance Inc (WBA)” was published by Community Financial News and is the property of of Community Financial News. If you are reading this piece on another domain, it was copied illegally and republished in violation of US and international trademark and copyright legislation. The legal version of this piece can be read at https://www.com-unik.info/2017/12/22/jaffetilchin-investment-partners-llc-takes-368000-position-in-walgreens-boots-alliance-inc-wba.html.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit